Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/05/2003EP1358886A1 Excretion accelerator for accumulative chlorine compound
11/05/2003EP1358884A1 Preventives for microbial infections
11/05/2003EP1358883A1 Re-epithelializing pharmaceutical compositions containing xanthan gum
11/05/2003EP1358882A1 Use of estriol sulfamate prodrugs for the treatment of autoimmune diseases
11/05/2003EP1358881A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
11/05/2003EP1358880A1 Medicinal composition for treatment of chronic cardiac failure
11/05/2003EP1358879A1 Antilipemic agents
11/05/2003EP1358878A1 Remedies/preventives for inflammatory diseases
11/05/2003EP1358876A1 Microcapsules containing anti-acne agents
11/05/2003EP1358872A1 Use of mixtures of active compounds comprising azelaic acid and glycyrrhetic acid in the treatment of acne
11/05/2003EP1358868A2 Cosmetic composition for increasing hair growth and/or for preventing or delaying hair loss
11/05/2003EP1358348A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/05/2003EP1358332A2 A serpin in bifidobacteria
11/05/2003EP1358328A2 Regulation of human serotonin-like g protein-coupled recepter
11/05/2003EP1358215A2 Glycosaminoglycans derived from k5 polysaccharide having high antithrombin activity and process for their preparation
11/05/2003EP1358198A1 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
11/05/2003EP1358189A1 Process for the preparation of a pyrazolo 4,3-d]pyrimidine derivative
11/05/2003EP1358188A2 Antagonists of mcp-1 function and methods of use thereof
11/05/2003EP1358187A2 Naphthyridine derivatives
11/05/2003EP1358186A1 Laulimalide derivatives
11/05/2003EP1358185A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
11/05/2003EP1358184A1 Substituted alkylamine derivatives and methods of use
11/05/2003EP1358183A2 Cysteine protease inhibitors
11/05/2003EP1358182A1 Diazocine derivatives and their use as tryptase inhibitors
11/05/2003EP1358181A1 Substituted pyrrolidines as ccr-3 receptor antagonists
11/05/2003EP1358180A2 Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358177A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/05/2003EP1358176A2 Inhibitors of cruzipain and other cysteine proteases
11/05/2003EP1358175A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
11/05/2003EP1358174A2 Inhibitors of cruzipain and other cysteine proteases
11/05/2003EP1358172A2 Amino ceramide-like compounds and therapeutic methods of use
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/05/2003EP1358169A2 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase
11/05/2003EP1358168A1 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
11/05/2003EP1358165A1 Imidazole derivatives
11/05/2003EP1358163A1 Melanocortin receptor agonists
11/05/2003EP1358162A1 Dihydroindole and tetrahydroquinoline derivatives
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1358160A1 Aminal diones as potassium channel openers
11/05/2003EP1358157A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands
11/05/2003EP1358156A2 Benz(g) indoles and their use as spla2 inhibitors
11/05/2003EP1358154A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/05/2003EP1358153A1 Ophthalmic compositions for treating ocular hypertension
11/05/2003EP1358150A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
11/05/2003EP1357977A2 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia
11/05/2003EP1357976A2 Pharmaceutical compositions having few side-effects
11/05/2003EP1357975A1 Medicament compositions with negligible side-effects containing betamimetics
11/05/2003EP1357974A1 Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
11/05/2003EP1357955A1 Drug delivery from stents
11/05/2003EP1357944A2 Perylenequinones for use with immunotherapy agents
11/05/2003EP1357936A1 BIOCATALYTIC AND BIOMIMETIC GENERATION OF NITRIC OXIDE i IN SITU /i AT SUBSTRATE/BLOOD INTERFACES
11/05/2003EP1357935A2 Method of reducing side effects of chemotherapy in cancer patients
11/05/2003EP1357932A1 Crystal modification of a cyclic depsipeptide having improved strength
11/05/2003EP1357930A2 Histidine-rich glycoprotein
11/05/2003EP1357919A1 Therapy-enhancing glucan
11/05/2003EP1357918A2 Metabolic controlled fermentation process for carbamoyl tobramycin production
11/05/2003EP1357917A2 Use of carbohydrates for eliminating intestinal infections in animals
11/05/2003EP1357916A2 Two-component anti-emetic composition comprising dexamethasone and metoclopramide
11/05/2003EP1357915A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO 4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/05/2003EP1357913A1 Heterocyclic inhibitors of glycine transporter 2
11/05/2003EP1357912A2 Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration
11/05/2003EP1357911A1 Use of betaine in functional products having blood pressure lowering effects
11/05/2003EP1357910A2 Method for preventing and treating visceral pain and gastrointestinal disorders
11/05/2003EP1357909A1 Il-8 receptor antagonists
11/05/2003EP1357908A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
11/05/2003EP1357907A2 Method of treating the syndrome of coronary heart disease risk factors in humans
11/05/2003EP1357906A2 Blockade of sodium channels by phenol derivatives
11/05/2003EP1357905A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
11/05/2003EP1357904A2 Use of pyrazolo 4,3-d]pyrimidines
11/05/2003EP1357903A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO b]THIOPHENE AND SALTS THEREOF
11/05/2003EP1357901A2 Process
11/05/2003EP1357900A2 Process for production of nanoparticles and microparticles by spray freezing into liquid
11/05/2003EP1357899A2 Oral itraconazole formulations and methods of making the same
11/05/2003EP1357898A2 Improved controlled release oral dosage form
11/05/2003EP1357892A1 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same
11/05/2003EP1357881A2 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
11/05/2003EP1357871A1 Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate
11/05/2003EP1357870A1 Bioadhesive cell foam film of sustained-release delivery
11/05/2003EP1357855A2 Ophthalmic compositions for treating ocular hypertension
11/05/2003EP1357811A1 Composition and method for smoke detoxification
11/05/2003EP1268480B1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
11/05/2003EP1268468B1 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs
11/05/2003EP1220858B1 Oxazinoquinolones useful for the treatment of viral infections
11/05/2003EP1212300B1 Azacycloalkanone serine protease inhibitors
11/05/2003EP1189749B1 Composite laminate and method for its production
11/05/2003EP1185262B1 Pharmaceutical compositions containing 8-chloro-3-(beta)-diethylaminoethyl)-4-methyl-7-ethoxycarbonyl-methoxy coumarin base and the salts thereof, with cholesterol-lowering activity
11/05/2003EP1178960B1 Vitamin d analogues and their pharmaceutical use
11/05/2003EP1176961B1 Nicotine delivery systems
11/05/2003EP1165494B1 Hsv primase inhibitors
11/05/2003EP1154996B1 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
11/05/2003EP1154762B1 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
11/05/2003EP1140113B1 Use of bisphosphonates for the prevention and treatment of infectious processes
11/05/2003EP1140058B1 N-formyl hydroxylamine derivatives as antibacterial agents
11/05/2003EP1135136B1 Pharmaceutical compositions containing olanzapine-n-oxide
11/05/2003EP1107973B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
11/05/2003EP1105141B1 Phosphatidylcholine as a medicament for the protection of mucosa
11/05/2003EP1090020B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
11/05/2003EP1082298B1 1-alpha-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
11/05/2003EP1068194B1 Pde iv inhibiting pyridine derivatives
1 ... 5287 5288 5289 5290 5291 5292 5293 5294 5295 5296 5297 5298 5299 5300 5301 5302 5303 5304 5305 5306 5307 ... 7860